Drug Profile
Research programme: gene therapies - TOT Biopharm
Alternative Names: TOT402Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator TOT Biopharm
- Class Gene therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Solid tumours
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Solid-tumours in China
- 03 Dec 2012 Early research in Solid tumours in China (unspecified route)